Artificial Intelligence in Epidemiology Market Strategic Growth Drivers and Outlook 2026 to 2035

Artificial Intelligence in Epidemiology Market Size is valued at 599.60 Million in 2025 and is predicted to reach 6,687.83 Million by the year 2035 at an 27.4% CAGR during the forecast period for 2026 to 2035.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1450

Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing global artificial intelligence in the epidemiology market are:
• Growing demand for disease monitoring in real-time
• Increasing the accessibility of health data
• Technological advancements

The following are the primary obstacles to artificial intelligence in the epidemiology market's expansion:
• High starting cost
• Lack of expertise
• Rising data privacy issues

Future expansion opportunities for the global artificial intelligence in epidemiology market include:
• Increasing integration of AI
• Increasing research and development activities
• Increasing investments in digital health

Key Industry Insights & Findings from the Report:
• Disease prediction is changing as a result of the increasing use of AI in epidemiology.
• The growing availability of health data drives the market for AI in epidemiology, the requirement for real-time outbreak prediction, and developments in machine learning.
• North America dominated the market and accounted for a revenue share of global revenue in 2023.
• One of the significant concerns restraining industry growth is the high starting cost and shortage of skilled personnel.

Market Analysis:
The application of artificial intelligence (AI) in epidemiology involves the use of advanced algorithms to analyze health data, forecast disease trends, and support evidence-based public health decision-making. Market expansion in this segment is driven by advancements in machine learning techniques, the growing demand for timely outbreak detection, and increased accessibility to comprehensive health datasets.

Additionally, the ongoing digital transformation of healthcare systems, coupled with substantial investments from both public and private stakeholders and improvements in computational infrastructure, is accelerating the adoption of AI-enabled solutions. These developments enhance resource allocation, strengthen disease surveillance, and improve overall public health response capabilities.

Read Overview Report- https://www.insightaceanalytic.com/report/global-artificial-intelligence-in-epidemiology-market/1450

List of Prominent Players in the Artificial Intelligence in Epidemiology Market:
• Cognizant Technology Solutions Corporation
• Cerner Corporation (Oracle)
• Epic Systems Corporation
• eClinicalWorks LLC
• Alphabet Inc.
• Komodo Health
• Microsoft Corporation
• Meditech
• Predixion Software
• Siemens Healthineers AG
• Intel Corporation
• Bayer Healthcare
• Artificial Intelligence for Medical Epidemiology (AIME)
• Cardiolyse
• SAS Institute, Inc.

Recent Developments:
• In January 2025, Gilead Sciences, a biopharmaceutical company, and Cognizant announced an extension of their long-standing partnership. This partnership intends to unlock even greater value for Gilead as it pursues breakthroughs to prevent and treat life-threatening diseases.
• In December 2024, Zscaler and Cognizant are expanding their collaboration to assist businesses in various sectors in streamlining and transforming their security posture through the use of a cutting-edge, AI-powered zero-trust cloud security platform to counteract changing cyber threats.
• In September 2024, Oracle Cloud Infrastructure AI infrastructure is being used by Evidium. This healthcare AI firm prioritizes safety, transparency, and dependability to further its goals of developing trustworthy AI and expanding medical knowledge and science. Evidium is using OCI AI infrastructure to train and develop a large number of AI models that support its AI platform.

Market Dynamics: AI in Epidemiology
Drivers:
The global market for artificial intelligence (AI) in epidemiology is being propelled by increasing demand for real-time disease surveillance. Healthcare systems worldwide require timely insights into disease transmission to enable rapid, targeted interventions, particularly in the context of recurring outbreaks and rapidly evolving pathogens.

AI-powered analytics facilitate the efficient processing of large-scale health datasets, supporting the identification of emerging trends and accurate forecasting of disease progression. These capabilities enhance public health decision-making, optimize resource allocation, and strengthen preparedness measures. Furthermore, growing investments in AI-enabled epidemiological monitoring solutions are driving adoption and contributing to sustained market growth.

Challenges:
Despite its transformative potential, AI adoption in epidemiology faces significant barriers. High initial investment requirements for specialized software, high-performance computing infrastructure, and skilled personnel pose financial challenges, particularly for smaller organizations and healthcare systems in developing regions. Additionally, the complexity and costs associated with integrating AI technologies into existing healthcare frameworks can impede implementation. Consequently, while AI offers considerable benefits for disease surveillance and management, the substantial upfront expenditures remain a key constraint on broader adoption and market expansion.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1450

North America Is Expected To Grow With the Highest CAGR During The Forecast Period
The North American market for artificial intelligence (AI) in epidemiology is projected to capture a substantial share of global revenue and achieve strong growth at a notable compound annual growth rate (CAGR) over the forecast period. This growth is supported by the region's advanced healthcare infrastructure, extensive adoption of digital health technologies, and significant investments in AI-focused research and development initiatives.

The implementation of AI in epidemiological applications is further facilitated by access to high-quality health data, well-defined regulatory frameworks, and strategic collaborations between technology providers and public health agencies. Additionally, the presence of a highly skilled workforce-including researchers, data scientists, and healthcare professionals-enables the effective development, deployment, and adoption of AI-driven solutions that enhance disease surveillance and strengthen public health management.

Segmentation of Artificial Intelligence in Epidemiology Market-
By Development-
• Web-Based
• Cloud-Based
By Application-
• Infection Prediction and Forecasting
• Disease and Syndromic Surveillance
By End-User-
• Government and State Agencies
• Research Labs
• Pharmaceutical and Biotechnology Companies
• Healthcare Providers
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.